NTLA · Intellia Therapeutics, Inc.
Market Cap
$1.78B
Shares
140.13M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| John Leonard | CEO | $5,063,899 |
| John M. Leonard, M.D. | President, Chief Executive Officer | $5,063,899 |
| Edward J. Dulac III | Executive Vice President, Chief Financial Officer and Treasurer | $2,168,505 |
| David Lebwohl | Executive Vice President, Chief Medical Officer | $1,984,724 |
| James Basta | Executive Vice President, General Counsel and Corporate Secretary | $1,846,597 |
| Birgit Schultes | Executive Vice President, Chief Scientific Officer | $1,740,083 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| John Leonard | CEO | $15,330,547 |
| John M. Leonard, M.D. | President, Chief Executive Officer | $15,330,547 |
| Edward J. Dulac III | Executive Vice President, Chief Financial Officer and Treasurer | $6,694,737 |
| David Lebwohl | Executive Vice President, Chief Medical Officer | $5,577,407 |
| Laura Sepp-Lorenzino | Executive Vice President, Chief Scientific Officer | $5,505,150 |
| James Basta | Executive Vice President, General Counsel and Corporate Secretary | $4,872,670 |
| Glenn Goddard | Former Executive Vice President, Chief Financial Officer and Treasurer | $4,447,173 |
| Michael P. Dube | Vice President, Chief Accounting Officer, Former Interim Principal Financial Officer | $1,342,904 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| John Leonard | CEO | $11,657,262 |
| John M. Leonard, M.D. | President, Chief Executive Officer | $11,657,262 |
| David Lebwohl | Executive Vice President, Chief Medical Officer | $4,257,962 |
| Laura Sepp-Lorenzino | Executive Vice President, Chief Scientific Officer | $4,186,105 |
| James Basta | Executive Vice President, General Counsel and Corporate Secretary | $3,994,791 |
| Glenn Goddard | Former Executive Vice President, Chief Financial Officer and Treasurer | $3,818,820 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| John M. Leonard, M.D. | President, Chief Executive Officer | $10,096,590 |
| John Leonard | CEO | $10,096,590 |
| Derek Hicks | Executive Vice President, Chief Business Officer | $5,081,938 |
| David Lebwohl | Executive Vice President, Chief Medical Officer | $3,716,964 |
| Laura Sepp-Lorenzino | Executive Vice President, Chief Scientific Officer | $3,716,128 |
| James Basta | Executive Vice President, General Counsel and Corporate Secretary | $3,625,229 |
| Glenn Goddard | Former Executive Vice President, Chief Financial Officer and Treasurer | $3,434,837 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| James Basta | Executive Vice President, General Counsel and Corporate Secretary | $15,072,959 |
| John M. Leonard, M.D. | President, Chief Executive Officer | $9,773,560 |
| John Leonard | CEO | $9,773,560 |
| Laura Sepp-Lorenzino | Executive Vice President, Chief Scientific Officer | $4,579,749 |
| David Lebwohl | Executive Vice President, Chief Medical Officer | $4,265,559 |
| Glenn Goddard | Executive Vice President, Chief Financial Officer and Treasurer | $4,053,349 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| John M. Leonard, M.D. | President, Chief Executive Officer | $3,635,676 |
| John Leonard | CEO | $3,635,676 |
| David Lebwohl | Executive Vice President, Chief Medical Officer | $2,078,788 |
| Andrew D. Schiermeier | Executive Vice President, Chief Operating Officer | $1,718,528 |
| Laura Sepp-Lorenzino | Executive Vice President, Chief Scientific Officer | $1,690,526 |
| Glenn Goddard | Executive Vice President, Chief Financial Officer and Treasurer | $1,563,511 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Laura Sepp-Lorenzino | Executive Vice President, Chief Scientific Officer | $1,762,489 |
| Andrew D. Schiermeier | Executive Vice President, Chief Operating Officer | $1,227,875 |
| John M. Leonard, M.D. | President, Chief Executive Officer | $903,786 |
| John Leonard | CEO | $903,786 |
| José Rivera | Executive Vice President, General Counsel | $637,649 |
| Glenn Goddard | Executive Vice President, Chief Financial Officer and Treasurer | $541,844 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| John M. Leonard, M.D. | President, Chief Executive Officer | $9,708,330 |
| John Leonard | CEO | $9,708,330 |
| Andrew D. Schiermeier | Executive Vice President, Chief Operating Officer | $2,925,306 |
| José Rivera | Executive Vice President, General Counsel | $2,646,896 |
| Glenn Goddard | Executive Vice President, Chief Financial Officer and Treasurer | $2,016,413 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| José Rivera | Executive Vice President, General Counsel | $2,853,059 |
| John Leonard | CEO | $2,592,874 |
| John M. Leonard, M.D. | President, Chief Executive Officer | $2,592,874 |
Key facts
CIK
1652130
CUSIP
45826J105
13F (30d)
241 filings
233 filers
Visit website
Investor relations